United States · Who invested in Global Blood Therapeutics?
Global Blood Therapeutics's investors include RA Capital Management, Wellington Management, Deerfield, Third Rock Ventures and Sabby Capital.
20122014201620182020
$41MSeries A$48MSeries B$300MDebt
United States · Funded startup
Who invested in Global Blood Therapeutics
Funding summaryUpdated 26 Oct 2026
$389Mraised across 3 rounds since 2012, from 3 sources
$41MSeries A$48MSeries B$300MDebt
- Latest round
- Debt, $300MDec 2021
- Step-upi
- 6.3×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $41M Jun 2012
- Biggest round
- $300M Debt · Dec 2021
- Usual gap between rounds
- 6.9 years the median of 2
The rounds
- Dec 2021
- Jan 2015Series B$48M4 new
From a historical funding recordSEC filing: $48M sold, first sale Dec 2014
- Jun 2012
Founders and team
From the SEC filings it signed: 2 on the team.
- John W. SchembriExecutive Officeri
- Ted W. LoveExecutive Officer, Directori
On the board, as filediCharles W. HomcyKevin W. Starr
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2012Series B2015Debt2021
RA Capital Management
Wellington Management
Deerfield
Third Rock VenturesSabby Capital
RA Capital ManagementWellington ManagementDeerfieldThird Rock VenturesSabby CapitalEveryone who backed them
Sabby CapitalPrivate equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Global Blood Therapeutics
How much has Global Blood Therapeutics raised?
Global Blood Therapeutics has raised $389M across 3 rounds since 2012.
When did Global Blood Therapeutics last raise?
Global Blood Therapeutics's most recent round was a Debt of $300M in Dec 2021.
What was Global Blood Therapeutics's biggest round?
Its most recent round, $300M in Dec 2021, is also its largest on record.
Who backed Global Blood Therapeutics first?
Global Blood Therapeutics's first round on record, in Jun 2012, was backed by Third Rock Ventures.
What stage is Global Blood Therapeutics at?
Global Blood Therapeutics's latest named round is a Debt, in Dec 2021.
Where is Global Blood Therapeutics based?
Global Blood Therapeutics is based in the United States.
Companies like Global Blood Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.